436 related articles for article (PubMed ID: 26715507)
1. Constitutive expression of AhR and BRCA-1 promoter CpG hypermethylation as biomarkers of ERα-negative breast tumorigenesis.
Romagnolo DF; Papoutsis AJ; Laukaitis C; Selmin OI
BMC Cancer; 2015 Dec; 15():1026. PubMed ID: 26715507
[TBL] [Abstract][Full Text] [Related]
2. Genistein Prevents
Romagnolo DF; Donovan MG; Papoutsis AJ; Doetschman TC; Selmin OI
Curr Dev Nutr; 2017 Jun; 1(6):e000562. PubMed ID: 29955703
[No Abstract] [Full Text] [Related]
3. The ligand status of the aromatic hydrocarbon receptor modulates transcriptional activation of BRCA-1 promoter by estrogen.
Hockings JK; Thorne PA; Kemp MQ; Morgan SS; Selmin O; Romagnolo DF
Cancer Res; 2006 Feb; 66(4):2224-32. PubMed ID: 16489025
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor subtype- and promoter-specific modulation of aryl hydrocarbon receptor-dependent transcription.
Wihlén B; Ahmed S; Inzunza J; Matthews J
Mol Cancer Res; 2009 Jun; 7(6):977-86. PubMed ID: 19470599
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Activation of
Donovan MG; Selmin OI; Doetschman TC; Romagnolo DF
Nutrients; 2019 Oct; 11(11):. PubMed ID: 31652854
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol prevents epigenetic silencing of BRCA-1 by the aromatic hydrocarbon receptor in human breast cancer cells.
Papoutsis AJ; Lamore SD; Wondrak GT; Selmin OI; Romagnolo DF
J Nutr; 2010 Sep; 140(9):1607-14. PubMed ID: 20631324
[TBL] [Abstract][Full Text] [Related]
8. Arsenic‑induced BRCA1 CpG promoter methylation is associated with the downregulation of ERα and resistance to tamoxifen in MCF7 breast cancer cells and mouse mammary tumor xenografts.
Selmin OI; Donovan MG; Skovan B; Paine-Murieta GD; Romagnolo DF
Int J Oncol; 2019 Mar; 54(3):869-878. PubMed ID: 30664189
[TBL] [Abstract][Full Text] [Related]
9. Activation of the aromatic hydrocarbon receptor pathway is not sufficient for transcriptional repression of BRCA-1: requirements for metabolism of benzo[a]pyrene to 7r,8t-dihydroxy-9t,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
Jeffy BD; Chirnomas RB; Chen EJ; Gudas JM; Romagnolo DF
Cancer Res; 2002 Jan; 62(1):113-21. PubMed ID: 11782367
[TBL] [Abstract][Full Text] [Related]
10. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
Tang B; Jiang J
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
[TBL] [Abstract][Full Text] [Related]
11. Co-planar 3,3',4,4',5-pentachlorinated biphenyl and non-co-planar 2,2',4,6,6'-pentachlorinated biphenyl differentially induce recruitment of oestrogen receptor alpha to aryl hydrocarbon receptor target genes.
Matthews J; Wihlén B; Heldring N; MacPherson L; Helguero L; Treuter E; Haldosén LA; Gustafsson JA
Biochem J; 2007 Sep; 406(2):343-53. PubMed ID: 17511620
[TBL] [Abstract][Full Text] [Related]
12. 12-O-tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells.
Spink BC; Fasco MJ; Gierthy JF; Spink DC
J Cell Biochem; 1998 Sep; 70(3):289-96. PubMed ID: 9706865
[TBL] [Abstract][Full Text] [Related]
13. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
14. Aryl hydrocarbon receptor modulation of estrogen receptor α-mediated gene regulation by a multimeric chromatin complex involving the two receptors and the coregulator RIP140.
Madak-Erdogan Z; Katzenellenbogen BS
Toxicol Sci; 2012 Feb; 125(2):401-11. PubMed ID: 22071320
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of inhibitory aryl hydrocarbon receptor-estrogen receptor/Sp1 cross talk in breast cancer cells.
Khan S; Barhoumi R; Burghardt R; Liu S; Kim K; Safe S
Mol Endocrinol; 2006 Sep; 20(9):2199-214. PubMed ID: 16675542
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells.
Safe S; Wormke M; Samudio I
J Mammary Gland Biol Neoplasia; 2000 Jul; 5(3):295-306. PubMed ID: 14973392
[TBL] [Abstract][Full Text] [Related]
17. BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers.
Vos S; Moelans CB; van Diest PJ
Breast Cancer Res; 2017 May; 19(1):64. PubMed ID: 28569220
[TBL] [Abstract][Full Text] [Related]
18. Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue.
Yang X; Solomon S; Fraser LR; Trombino AF; Liu D; Sonenshein GE; Hestermann EV; Sherr DH
J Cell Biochem; 2008 May; 104(2):402-17. PubMed ID: 18059014
[TBL] [Abstract][Full Text] [Related]
19. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters.
Matthews J; Wihlén B; Thomsen J; Gustafsson JA
Mol Cell Biol; 2005 Jul; 25(13):5317-28. PubMed ID: 15964790
[TBL] [Abstract][Full Text] [Related]
20. Aryl hydrocarbon receptor-independent activation of estrogen receptor-dependent transcription by 3-methylcholanthrene.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2006 Jun; 213(2):87-97. PubMed ID: 16257430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]